Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124621 | SCV000168054 | benign | not specified | 2013-04-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000124621 | SCV000308528 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV002055516 | SCV002403231 | benign | Neuronal ceroid lipofuscinosis | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498595 | SCV002812018 | likely benign | Neuronal ceroid lipofuscinosis 10 | 2021-10-08 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000675952 | SCV005322028 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000675952 | SCV000801681 | likely benign | not provided | 2017-04-25 | no assertion criteria provided | clinical testing |